Sphere Fluidics
Booth Number 14
October 3-4, 2024
The Westin San Diego
San Diego, CA, USA
Visit our booth during the show to learn more about how our cutting-edge technologies are driving innovation in microfluidic biology, or take a look at our presentation by Richard Hammond, CTO.
Insights and Innovations: Join CTO Richard Hammond for a Dynamic Presentation and Poster Showcase
More details coming soon. Stay tuned!
Richard Hammond, Chief Technology Officer (CTO), Sphere Fluidics
About Richard Hammond
Richard is responsible for Research & Development (R&D) at Sphere Fluidics. He brings over 20 years of experience in developing cutting-edge healthcare and life sciences products. He has held numerous senior positions responsible for product and technology development. At Alere Inc., he led major cross-company R&D programs including the Alere i platform, the world’s first CLIA-waived point of-care molecular infectious disease diagnostic device.
Richard founded Cambridge Consultants’ Bioinnovation group, providing biotechnical consultancy services, and recently was VP of Technology at DNA Electronics developing sequence-based diagnostics. Richard has MA and MEng degrees from King’s College, University of Cambridge.
Join us at Biologics US 2024, where Sphere Fluidics will be at the forefront of discussions on overcoming the complexities in biologics development. This premier event, held on October 3-4, will bring together over 550 leaders from the pharmaceutical and biotech sectors to explore next-generation strategies and technologies that are shaping the future of biologics.
With 35 hours of insightful presentations and 11 hours of dedicated networking, this is your chance to connect with industry experts, explore innovative solutions, and discover how Sphere Fluidics can help advance your drug discovery workflow.
Visit the event website to register now
